| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6251368 | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec, 2012
(11 years ago) | |
|
US6251368 (Pediatric) | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun, 2013
(10 years ago) | |
| US6596260 | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
| US5658549 | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug, 2014
(9 years ago) | |
| US5674472 | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
|
US5658549 (Pediatric) | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb, 2015
(9 years ago) | |
|
US5674472 (Pediatric) | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr, 2015
(9 years ago) | |
| US6966467 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6315173 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6510969 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6938796 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6435372 | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US6161724 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6997349 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US7107986 | GLAXO GRP LTD | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
| US6431168 | GLAXO GRP LTD | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXO GRP LTD | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXO GRP LTD | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXO GRP LTD | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXO GRP LTD | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXO GRP LTD | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXO GRP LTD | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
|
US7500444 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Flovent Hfa is owned by Glaxo Grp Ltd.
Flovent Hfa contains Fluticasone Propionate.
Flovent Hfa has a total of 39 drug patents out of which 37 drug patents have expired.
Expired drug patents of Flovent Hfa are:
- US6251368
- US6251368*PED
- US6596260
- US5658549
- US5674472
- US6596260*PED
- US5658549*PED
- US5674472*PED
- US6966467
- US6170717
- US6315173
- US6510969
- US6938796
- US6435372
- US6161724
- US7143908
- US6997349
- US7107986
- US6431168
- US6315173*PED
- US6510969*PED
- US6170717*PED
- US6966467*PED
- US6997349*PED
- US6938796*PED
- US6435372*PED
- US6161724*PED
- US7143908*PED
- US7350676
- US6431168*PED
- US7107986*PED
- US7350676*PED
- US9861771
- US6743413
- US6743413*PED
- US7832351
- US7832351*PED
Flovent Hfa was authorised for market use on 14 May, 2004.
Flovent Hfa is available in aerosol, metered;inhalation dosage forms.
Flovent Hfa can be used as method of treating a condition capable of treatment by inhalation, e.g. asthma, comprising administration of a formulation claimed in us patent no. 6743413, a method of treating respiratory disorders, e.g., asthma, which comprises administration by inhalation of an effective amount of a pharmaceutical formulation as claimed in us patent no. 5658549.
The generics of Flovent Hfa are possible to be released after 26 August, 2026.
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 14 May, 2004
Treatment: A method of treating respiratory disorders, e.g., asthma, which comprises administration by inhalation of an effective amount of a pharmaceutical formulation as claimed in us patent no. 5658549; Metho...
Dosage: AEROSOL, METERED;INHALATION
FLOVENT HFA family patents
